Total medical devices industry M&A deals worth $4.6bn were announced in North America in July 2022, led by’s $3.9bn acquisition of 1Life Healthcare, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 529.9% over the previous month of $735.1m and a drop of 26.5% when compared with the last 12-month average of $6.3bn.

North America held a 99.78% share of the global medical devices industry M&A deal value that totalled $4.64bn in July 2022. With a 99.78% share and deals worth $4.63bn, the US was the top country in North America’s M&A deal value across medical devices industry.

In terms of M&A deal activity, North America recorded 24 deals during July 2022, marking an increase of 20.00% over the previous month and a flat growth over the 12-month average. The US recorded 21 deals during the month.

North America medical devices industry M&A deals in July 2022: Top deals

The top five medical devices industry M&A deals accounted for 99.8% of the overall value during July 2022.

The combined value of the top five medical devices deals stood at $4.62bn, against the overall value of $4.6bn recorded for the month.

The top five medical devices industry M&A deals of July 2022 tracked by GlobalData were:

1) $3.9bn acquisition deal with 1Life Healthcare

2) The $500m acquisition of OpenEye Scientific Software by Cadence Design Systems

3) Health Sciences Acquisitions2 $158m acquisition deal with Orchestra BioMed

4) The $52.5m acquisition of Palamedrix by SomaLogic

5) Inotiv $11m acquisition deal with Protypia